Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Degott

Showing results (241-250 of 320) with videos related to

Pageof 32
Sort By:
Gastroenterology|November 1, 1995
Ischemic hepatitis due to obstructive sleep apneaP Mathurin, F Durand, N Ganne, et al.
Hepatology (Baltimore, Md.)|April 1, 1995
Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazidF Durand, J Bernuau, D Pessayre, et al.
Journal of Hepatology|April 3, 2001
Hepatitis after intravenous buprenorphine misuse in heroin addictsA Berson, A Gervais, D Cazals, et al.
Histopathology|May 26, 2006
Human pancreatic mucinous cystadenoma is characterized by distinct mucin, cytokeratin and CD10 expression compared with intraductal papillary-mucinous adenomaA Handra-Luca, J-F Fléjou, P Rufat, et al.
Journal of Viral Hepatitis|June 30, 2005
Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosisF Marrache, Y Consigny, M P Ripault, et al.
Histopathology|April 17, 1998
Expression of vascular endothelial growth factor in digestive neuroendocrine tumoursB Terris, J Y Scoazec, L Rubbia, et al.
Autoimmunity|January 1, 1989
Characteristics of clometacin-induced hepatitis with special reference to the presence of anti-actin cable antibodiesS Islam, F Mekhloufi, J M Paul, et al.
Hepatology (Baltimore, Md.)|June 30, 2001
Cigarette smoking and hepatic lesions in patients with chronic hepatitis CF Pessione, M J Ramond, C Njapoum, et al.
Transplantation|February 1, 1980
Is renal transplantation involved in post-transplantation liver disease? A prospective studyF Degos, C Degott, J Bedrossian, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drugJ Geneve, B Hayat-Bonan, G Labbe, et al.
Pageof 32

Showing results (241-250 of 320) with videos related to

Sort By:
Pageof 32
Gastroenterology|November 1, 1995
Ischemic hepatitis due to obstructive sleep apneaP Mathurin, F Durand, N Ganne, et al.
Hepatology (Baltimore, Md.)|April 1, 1995
Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazidF Durand, J Bernuau, D Pessayre, et al.
Journal of Hepatology|April 3, 2001
Hepatitis after intravenous buprenorphine misuse in heroin addictsA Berson, A Gervais, D Cazals, et al.
Histopathology|May 26, 2006
Human pancreatic mucinous cystadenoma is characterized by distinct mucin, cytokeratin and CD10 expression compared with intraductal papillary-mucinous adenomaA Handra-Luca, J-F Fléjou, P Rufat, et al.
Journal of Viral Hepatitis|June 30, 2005
Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosisF Marrache, Y Consigny, M P Ripault, et al.
Histopathology|April 17, 1998
Expression of vascular endothelial growth factor in digestive neuroendocrine tumoursB Terris, J Y Scoazec, L Rubbia, et al.
Autoimmunity|January 1, 1989
Characteristics of clometacin-induced hepatitis with special reference to the presence of anti-actin cable antibodiesS Islam, F Mekhloufi, J M Paul, et al.
Hepatology (Baltimore, Md.)|June 30, 2001
Cigarette smoking and hepatic lesions in patients with chronic hepatitis CF Pessione, M J Ramond, C Njapoum, et al.
Transplantation|February 1, 1980
Is renal transplantation involved in post-transplantation liver disease? A prospective studyF Degos, C Degott, J Bedrossian, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1987
Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drugJ Geneve, B Hayat-Bonan, G Labbe, et al.
Pageof 32